Clinical Trial

5-MTHF Supplementation for Treatment of Type 1 Diabetes Patients

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated April 16, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the improvement of autoimmune status in patients with Type 1 Diabetes (T1D) through supplementation with 5-Methyltetrahydrofolate, and to explore the safety and efficacy of this treatment. The research seeks to provide new methods for the treatment of T1D and offer innovative ideas for enhancing the quality of life of T1D patients.
Trial Details
NCT Number NCT06930144
Lead Sponsor Shanghai Changzheng Hospital
Conditions Type 1 Diabetes Mellitus
Enrollment 34 participants
Start Date 2025-04
Primary Completion 2026-04 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2025-04-16